A NEW APPROACH TO WELLNESS FOR YAKIMA VALLEY
The future of psychedelic medicine is here.
Ketamine and Spravato therapy are opening soon in Yakima for adults living with treatment-resistant depression, anxiety, PTSD, and chronic pain.
Founded by an experienced clinical team dedicated to caring for patients who have been through years of trial and error and deserve something that actually helps.
A different approach, when conventional treatment has fallen short.
Ketamine was first approved by the FDA as an anesthetic in the 1970s. In the decades since, researchers and clinicians have found that at carefully controlled doses, it offers something traditional antidepressants often cannot: rapid, meaningful relief for people with treatment-resistant conditions.
Rapid Relief
Unlike conventional antidepressants, which may take weeks to produce noticeable effects, ketamine-based treatments can work more quickly for some patients. Many report meaningful changes in mood and perspective within hours or days. For those who have struggled to find relief, a faster-acting option may offer a different path forward.
Backed by Research
Ketamine and Spravato have been extensively studied for depression and other conditions. Spravato received FDA approval for treatment-resistant depression in 2019, adding an important new option for patients who have not responded adequately to traditional treatments. Research continues to explore ketamine’s potential across mental health care.
Clinically Supervised
Every treatment session takes place in our clinic with trained medical professionals overseeing your care. Treatment is carefully administered according to your individual needs, with appropriate monitoring throughout the experience. Our private, comfortable setting is designed to help you feel supported, safe, and at ease.
Rapid Relief
Unlike conventional antidepressants, which may take weeks to produce noticeable effects, ketamine-based treatments can work more quickly for some patients. Many report meaningful changes in mood and perspective within hours or days. For those who have struggled to find relief, a faster-acting option may offer a different path forward.
Backed by Research
Ketamine and Spravato have been extensively studied for depression and other conditions. Spravato received FDA approval for treatment-resistant depression in 2019, adding an important new option for patients who have not responded adequately to traditional treatments. Research continues to explore ketamine’s potential across mental health care.
Clinically Supervised
Every treatment session takes place in our clinic with trained medical professionals overseeing your care. Treatment is carefully administered according to your individual needs, with appropriate monitoring throughout the experience. Our private, comfortable setting is designed to help you feel supported, safe, and at ease.
Evidence-based care for the conditions most resistant to conventional treatment.
I.
Treatment-Resistant Depression
When two or more antidepressants haven't brought relief.
II.
Anxiety Disorders
Generalized anxiety, panic, and severe social anxiety.
III.
PTSD & Trauma
Including combat-related and complex trauma responses.
IV.
OCD
Intrusive thoughts and compulsive patterns.
V.
Chronic Pain
Including fibromyalgia and neuropathic pain.
VI.
Suicidal Thoughts
Rapid relief in crisis and severe ideation.
FOR PROSPECTIVE PATIENTS
Thinking ketamine might help?
Join our early interest list and we'll reach out personally when scheduling opens. We can answer your questions along the way, no obligation.
FOR REFERRING PROVIDERS
Have patients who could benefit?
We're building relationships with psychiatrists, primary care providers, and therapists in Yakima County. Let us know you're interested in a referral partnership.
Contact:
Phone: (509) 509-2171
Fax: (509) 436-0475
Location:
901 W. Yakima Ave. Suite 4B
Yakima, WA 98902
Email: